TAKEDA PHARMACEUTICAL COMPANY LIMITED
corporate_fare Company Profile
TAKEDA PHARMACEUTICAL COMPANY LIMITED (NYSE:TAK) is a publicly traded company in the Life Sciences sector. Wiseek monitors TAK SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Takeda Issues $539M in Shares for Employee Long-Term Incentive Plan
- Takeda Finalizes $2.5B Antitrust Provision, Revising FY2025 Reported Net Profit to a Loss
- Takeda Refiles Shelf Registration for JPY 240B Long-Term Incentive Plan, Expects 1.1% Dilution
- Takeda Proposes Increased Dividend and Board Restructuring for Annual Shareholder Meeting
- Takeda Reports $813M Impairment Losses & $445M Restructuring Costs in FY2026 Financial Notes
Financial Snapshot
Insider Transactions
TAK files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.